Ang II-stimulated migration of vascular smooth muscle cells is dependent on LR11 in mice

Journal of Clinical Investigation

Volumn 118, Issue 8, 2008, Pages 2733-2746

  Jiang, Meizi ^a   Bujo, Hideaki ^a   Ohwaki, Kenji ^a   Unoki, Hiroyuki ^a   Yamazaki, Hiroyuki ^b   Kanaki, Tatsuro ^a   Shibasaki, Manabu ^a,b   Azuma, Kazuhiko ^a   Harigaya, Kenichi ^a   Schneider, Wolfgang J ^c   Saito, Yasushi ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KOWA COMPANY LTD   (Japan)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; FOCAL ADHESION KINASE; MEGALIN; MITOGEN ACTIVATED PROTEIN KINASE; RAC1 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; CELL ISOLATION; CELL MIGRATION; CONTROLLED STUDY; DYSLIPIDEMIA; ENZYME ACTIVATION; FEMALE; GENE DISRUPTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMBRANE FORMATION; MOUSE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NONHUMAN; PRIORITY JOURNAL; SCHOOL CHILD; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ANGIOTENSIN II; ANIMALS; BIOLOGICAL MARKERS; CELL MOVEMENT; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; DOSE-RESPONSE RELATIONSHIP, DRUG; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, KNOCKOUT; MODELS, BIOLOGICAL; MUSCLE, SMOOTH, VASCULAR; RECEPTORS, LDL; SOLUBILITY; TIME FACTORS;

EID: 48749127608     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI32381     Document Type: Article

References (48)

1. Ross, R. 1999. Atherosclerosis - an inflammatory disease. N. Engl. J. Med. 340:115-126.
2. Newby, A.C. 2005. Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. Physiol. Rev. 85:1-31.
3. Blasi, F., and Carmeliet, P. 2002. uPAR: a versatile signalling orchestrator. Nat. Rev. Mol. Cell. Biol. 3:932-943.
4. Reuning, U., Magdolen, V., Hapke, S., and Schmitt, M. 2003. Molecular and functional interdependence of the urokinase-type plasminogen activator system with integrins. Biol. Chem. 384:1119-1131.
5. Herz, J., and Hui, D.Y. 2004. Lipoprotein receptors in the vascular wall. Curr. Opin. Lipidol. 15:175-181.
6. Gonias, S.L., Wu, L., and Salicioni, A.M. 2004. Low density lipoprotein receptor-related protein: regulation of the plasma membrane proteome. Thromb. Haemost. 91:1056-1064.
7. Bujo, H., and Saito, Y. 2006. Modulation of smooth muscle cell migration by members of the low-density lipoprotein receptor family. Arterioscler. Thromb. Vasc. Biol. 26:1246-1252.
8. Yamazaki, H., et al. 1996. Elements of neural adhesion molecules and a yeast vacuolar protein sorting receptor are present in a novel mammalian low density lipoprotein receptor family member. J. Biol. Chem. 271:24761-24768.
9. 2-macroglobulin receptor associated protein (RAP). J. Biol. Chem. 271:31379-31383.
10. Morwald, S., et al. 1997. A novel mosaic protein containing LDL receptor elements is highly conserved in humans and chickens. Arterioscler. Thromb. Vasc. Biol. 17:996-1002.
11. Zhu, Y., et al. 2004. LR11, an LDL receptor gene family member, is a novel regulator of smooth muscle cell migration. Circ. Res. 94:752-758.
12. Kanaki, T., et al. 1999. Expression of LR11, a mosaic LDL receptor family member, is markedly increased in atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 19:2687-2695.
13. Zhu, Y., et al. 2002. Enhanced expression of the LDL receptor family member LR11 increases migration of smooth muscle cells in vitro. Circulation. 105:1830-1836.
14. Jiang, M., et al. 2006. Pitavastatin attenuates the PDGF-induced LR11/uPA receptor-mediated migration of smooth muscle cells. Biochem. Biophys. Res. Commun. 348:1367-1377.
15. Xi, X.P., et al. 1999. Central role of the MAPK pathway in AngII-mediated DNA synthesis and migration in rat vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 19:73-82.
16. 1-type angiotensin receptor in oxidative stress and atherogenesis: part I: oxidative stress and atherogenesis. Circulation. 105:393-396.
17. Zuo, L., et al. 2005. Caveolin-1 is essential for activation of Rac1 and NAD(P)H oxidase after angiotensin II type 1 receptor stimulation in vascular smooth muscle cells: role in redox signaling and vascular hypertrophy. Arterioscler. Thromb. Vasc. Biol. 25:1824-1830.
18. Horiuchi, M., et al. 2003. Fluvastatin enhances the inhibitory effects of a selective angiotensin II type 1 receptor blocker, valsartan, on vascular neointimal formation. Circulation. 107:106-112.
19. O'Leary, D.H., et al. 1999. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N. Engl. J. Med. 340:14-22.
20. Ohwaki, K., et al. 2007. A secreted soluble form of LR11, specifically expressed in intimal smooth muscle cells, accelerates formation of lipid-laden macrophages. Arterioscler. Thromb. Vasc. Biol. 27:1050-1056.
21. Manabe, I., and Nagai, R. 2003. Regulation of smooth muscle phenotype. Curr. Atheroscler. Rep. 5:214-222.
22. Hermey, G., Sjogaard, S.S., Petersen, C.M., Nykjaer, A., and Gliemann, J. 2006. Tumour necrosis factor alpha-converting enzyme mediates ectodomain shedding of Vps10p-domain receptor family members. Biochem. J. 395:285-293.
23. Kitagawa, Y., et al. 2004.Impaired glucose tolerance is accompanied by decreased insulin sensitivity in tissues of mice implanted with cells that overexpress resistin. Diabetologia. 47:1847-1853.
24. Trommsdorff, M., et al. 1999. Reeler/Disabled-like disruption of neuronal migration in knockout mice lacking the VLDL receptor and ApoE receptor 2. Cell. 97:689-701.
25. Webb, D.J., Nguyen, D.H.D., Sankovic, M., and Gonias, S.L. 1999. The very low density lipoprotein receptor regulates urokinase receptor catabolism and breast cancer cell motility in vitro. J. Biol. Chem. 274:7412- 7420.
26. Webb, D.J., Nguyen, D.H.D., and Gonias, S.L. 2000. Extracellular signal-regulated kinase functions in the urokinase receptor-dependent pathway by which neutralization of low density lipoprotein receptor-related protein promotes fibrosarcoma cell migration and matrigel invasion. J. Cell Sci. 113:123-134.
27. Ma, Z., et al. 2002. Regulation of Rac1 activation by the low density lipoprotein receptor-related protein. J. Cell Biol. 159:1061-1070.
28. Zhu, Y., and Hui, D.Y. 2002. Low density lipoprotein receptor-related protein mediates apolipoprotein E inhibition of smooth muscle cell migration. J. Biol. Chem. 277:4141-4146.
29. Boucher, P., Gotthardt, M., Li, W.P., Anderson, R.G., and Herz, J. 2003. LRP: role in vascular wall integrity and protection from atherosclerosis. Science. 300:329-332.
30. Swertfeger, D.K., Bu, G., and Hui, D.Y. 2003. Apolipoprotein E binding to low density lipoprotein receptor-related protein-1 inhibits cell migration via activation of cAMP-dependent protein kinase A. J. Biol. Chem. 278:36257-36263.
31. Orr, A.W., Elzie, C.A., Kucik, D.F., and Murphy-Ullrich, J.E. 2003. Thrombospondin signaling through the calreticulin/LDL receptor-related protein co-complex stimulates random and directed cell migration. J. Cell. Sci. 116:2917-2927.
32. Tanaga, K., et al. 2004. LRP1B attenuates the migration of smooth muscle cells by reducing membrane localization of urokinase and PDGF receptors. Arterioscler. Thromb. Vasc. Biol. 24:1422-1428.
33. Seki, N., et al. 2005. LRP1B is a negative modulator of increased migration activity of intimal smooth muscle cells from rabbit aortic plaques. Biochem. Biophys. Res. Commun. 331:964-970.
34. Nykjaer, A., et al. 1997. Recycling of the urokinase receptor upon internalization of the uPA:serpin complexes. EMBO J. 16:2610-2620.
35. Liu, C.X., et al. 2001. The putative tumor suppressor LRP1B, a novel member of the low density lipoprotein (LDL) receptor family, exhibits both overlapping and distinct properties with the LDL receptor-related protein. J. Biol. Chem. 276:28889-28896.
36. Degryse, B., et al. 2001. Urokinase/urokinase receptor and vitronectin/alpha(v)beta(3) integrin induce chemotaxis and cytoskeleton reorganization through different signaling pathways. Oncogene. 20:2032-2043.
37. Cohn, R.D., et al. 2007. Angiotensin II type 1 receptor blockade attenuates TGF-beta-induced failure of muscle regeneration in multiple myopathic states. Nat. Med. 13:204-210.
38. Boucher, P., et al. 2007. LRP1 functions as an atheroprotective integrator of TGFbeta and PDGF signals in the vascular wall: implications for Marfan syndrome. PLoS ONE. 2:e448.
39. Rogaeva, E., et al. 2007. The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nat. Genet. 39:168-177.
40. Scherzer, C.R., et al. 2004. Loss of apolipoprotein E receptor LR11 in Alzheimer disease. Arch. Neurol. 61:1200-1205.
41. Sagare, A., et al. 2007. Clearance of amyloid-beta by circulating lipoprotein receptors. Nat. Med. 13:1029-1031.
42. Fujita, Y., et al. 2005. Association of nucleotide variations in the apolipoprotein B48 receptor gene (APOB48R) with hypercholesterolemia. J. Hum. Genet. 50:203-209.
43. Taira, K., et al. 2002. Positive family history for coronary heart disease and 'midband lipoproteins' are potential risk factors of carotid atherosclerosis in familial hypercholesterolemia. Atherosclerosis. 160:391-397.
44. Bujo, H., et al. 1994. Chicken oocyte growth is mediated by an eight ligand binding repeat member of the LDL receptor family. EMBO J. 13:5165-5175.
45. Kobayashi, K., et al. 2005. Targeted disruption of TGF-beta-Smad3 signaling leads to enhanced neointimal hyperplasia with diminished matrix deposition in response to vascular injury. Circ. Res. 96:904-912.
46. Hirata, T., Unoki, H., Bujo, H., Ueno, K., and Saito, Y. 2006. Activation of diacylglycerol O-acyltransferase 1 gene results in increased tumor necrosis factor-alpha gene expression in 3T3-L1 adipocytes. FEBS Lett. 580:5117-5121.
47. Bujo, H., et al. 1995. Mutant oocytic low density lipoprotein receptor gene family member causes atherosclerosis and female sterility. Proc. Natl. Acad. Sci. U. S. A. 92:9905-9909.
48. Redmond, E.M., et al. 2001. Endothelial cells inhibit flow-induced smooth muscle cell migration: role of plasminogen activator inhibitor-1. Circulation. 103:597-603.